Page last updated: 2024-10-26

ethosuximide and Acquired Aphasia with Convulsive Disorder

ethosuximide has been researched along with Acquired Aphasia with Convulsive Disorder in 2 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lagae, L1
Liukkonen, E1
Kantola-Sorsa, E1
Paetau, R1
Gaily, E1
Peltola, M1
Granström, ML1

Other Studies

2 other studies available for ethosuximide and Acquired Aphasia with Convulsive Disorder

ArticleYear
Rational treatment options with AEDs and ketogenic diet in Landau-Kleffner syndrome: still waiting after all these years.
    Epilepsia, 2009, Volume: 50 Suppl 7

    Topics: Anticonvulsants; Behavior Therapy; Benzodiazepines; Child; Combined Modality Therapy; Diet, Ketogeni

2009
Long-term outcome of 32 children with encephalopathy with status epilepticus during sleep, or ESES syndrome.
    Epilepsia, 2010, Volume: 51, Issue:10

    Topics: Adolescent; Anticonvulsants; Child; Cognition Disorders; Drug Therapy, Combination; Electroencephalo

2010